Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smitha Antony

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|July 9, 2009
Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibitionJosée Guirouilh-Barbat, Smitha Antony, Yves Pommier
Antioxidants & Redox Signaling|February 4, 2020
Inhibiting the Activity of NADPH Oxidase in CancerMariam M Konaté, Smitha Antony, James H Doroshow
Journal of Medicinal Chemistry|April 29, 2005
On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complexXiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Journal of Medicinal Chemistry|February 17, 2006
Total synthesis and biological evaluation of 22-hydroxyacuminatineXiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapyThomas S Dexheimer, Smitha Antony, Christophe Marchand, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2006
Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: versatile intermediates for the design and synthesis of topoisomerase I inhibitorsAndrew Morrell, Smitha Antony, Glenda Kohlhagen, et al.
Bioorganic & Medicinal Chemistry|September 8, 2004
Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitorsXiangshu Xiao, Smitha Antony, Glenda Kohlhagen, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitorsAndrew Morrell, Smitha Antony, Glenda Kohlhagen, et al.
Cancer Letters|August 31, 2013
Molecular mechanisms underlying chronic inflammation-associated cancersYongzhong Wu, Smitha Antony, Jennifer L Meitzler, et al.
Nucleic Acids Research|October 8, 2004
Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structuresSmitha Antony, Paola B Arimondo, Jian-Sheng Sun, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|July 9, 2009
Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibitionJosée Guirouilh-Barbat, Smitha Antony, Yves Pommier
Antioxidants & Redox Signaling|February 4, 2020
Inhibiting the Activity of NADPH Oxidase in CancerMariam M Konaté, Smitha Antony, James H Doroshow
Journal of Medicinal Chemistry|April 29, 2005
On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complexXiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Journal of Medicinal Chemistry|February 17, 2006
Total synthesis and biological evaluation of 22-hydroxyacuminatineXiangshu Xiao, Smitha Antony, Yves Pommier, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapyThomas S Dexheimer, Smitha Antony, Christophe Marchand, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2006
Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: versatile intermediates for the design and synthesis of topoisomerase I inhibitorsAndrew Morrell, Smitha Antony, Glenda Kohlhagen, et al.
Bioorganic & Medicinal Chemistry|September 8, 2004
Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitorsXiangshu Xiao, Smitha Antony, Glenda Kohlhagen, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitorsAndrew Morrell, Smitha Antony, Glenda Kohlhagen, et al.
Cancer Letters|August 31, 2013
Molecular mechanisms underlying chronic inflammation-associated cancersYongzhong Wu, Smitha Antony, Jennifer L Meitzler, et al.
Nucleic Acids Research|October 8, 2004
Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structuresSmitha Antony, Paola B Arimondo, Jian-Sheng Sun, et al.
Pageof 7